Last December 14, the IRIS-CC submitted the request for accreditation of its own CEIm to the General Directorate of Health Planning and Regulation of the Department of Health of the Generalitat de Catalunya.
The Ethics Committee for Research with Medicines, Health Products and Clinical Interventions (CEIm, from the acronym in Catalan) are independent bodies from the promoters of research projects and researchers and have the purpose of ensuring the protection of the rights, safety and well-being of the human beings who participate in research projects that may involve some physical or psychological risk. Decree 406/2006, of October 26, regulates these committees and establishes that they must be accredited by the General Directorate of Health Planning and Regulation of the Department of Health.
Once accredited, this committee will be in charge of the technical and ethical reports of all the research projects, agreements and clinical trials carried out at the IRIS-CC. In addition, a whole series of documentation must be presented annually, such as a report of activities and operating regulations, as well as renewing the accreditation periodically in order to guarantee the validity of the committee.
You can find more information about the CEIm of the IRIS-CC in the Clinical Trials section of our website.